Joshua Jennings
Stock Analyst at TD Cowen
(2.58)
# 2,172
Out of 5,116 analysts
80
Total ratings
45.83%
Success rate
3.88%
Average return
Main Sectors:
Stocks Rated by Joshua Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Maintains: Buy | $222 → $250 | $227.25 | +10.01% | 2 | Jan 22, 2026 | |
| EW Edwards Lifesciences | Upgrades: Buy | $90 → $97 | $81.36 | +19.22% | 2 | Jan 9, 2026 | |
| OBIO Orchestra BioMed Holdings | Initiates: Buy | $15 | $3.49 | +329.80% | 1 | Dec 10, 2025 | |
| CBLL CeriBell | Maintains: Buy | $36 → $20 | $20.61 | -2.96% | 3 | Nov 5, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $25 → $15 | $7.33 | +104.64% | 2 | Nov 5, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $85 → $50 | $28.96 | +72.65% | 4 | Nov 5, 2025 | |
| DXCM DexCom | Maintains: Buy | $100 → $84 | $73.04 | +15.01% | 2 | Oct 31, 2025 | |
| HUMA Humacyte | Maintains: Buy | $5 → $3.5 | $1.00 | +250.81% | 3 | Aug 12, 2025 | |
| AVR Anteris Technologies Global | Initiates: Buy | $15 | $5.97 | +151.26% | 1 | Jan 7, 2025 | |
| PODD Insulet | Maintains: Buy | $264 → $324 | $255.81 | +26.66% | 1 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $110 | $93.53 | +17.61% | 7 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $120 | $133.98 | -10.43% | 9 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $1.35 | +3,603.70% | 1 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $143 → $119 | $87.07 | +36.67% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $60 | $35.98 | +66.76% | 2 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $83 → $80 | $74.88 | +6.84% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $45 | $5.01 | +798.20% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $40 | $20.07 | +99.30% | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $365 → $400 | $369.56 | +8.24% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $60 | $68.18 | -12.00% | 4 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $34 | $19.89 | +70.94% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 → $18 | $7.50 | +140.00% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $6 → $25 | $18.13 | +37.89% | 1 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $130 | $109.30 | +18.94% | 9 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $5 | $2.19 | +128.31% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $117 | $102.96 | +13.64% | 3 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $450 | $2.20 | +20,354.55% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $12 | $14.83 | -19.08% | 1 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $306 → $275 | $203.48 | +35.15% | 1 | Feb 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $28 → $28 | $10.04 | +173.90% | 3 | Sep 5, 2018 |
Johnson & Johnson
Jan 22, 2026
Maintains: Buy
Price Target: $222 → $250
Current: $227.25
Upside: +10.01%
Edwards Lifesciences
Jan 9, 2026
Upgrades: Buy
Price Target: $90 → $97
Current: $81.36
Upside: +19.22%
Orchestra BioMed Holdings
Dec 10, 2025
Initiates: Buy
Price Target: $15
Current: $3.49
Upside: +329.80%
CeriBell
Nov 5, 2025
Maintains: Buy
Price Target: $36 → $20
Current: $20.61
Upside: -2.96%
Senseonics Holdings
Nov 5, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $7.33
Upside: +104.64%
PROCEPT BioRobotics
Nov 5, 2025
Maintains: Buy
Price Target: $85 → $50
Current: $28.96
Upside: +72.65%
DexCom
Oct 31, 2025
Maintains: Buy
Price Target: $100 → $84
Current: $73.04
Upside: +15.01%
Humacyte
Aug 12, 2025
Maintains: Buy
Price Target: $5 → $3.5
Current: $1.00
Upside: +250.81%
Anteris Technologies Global
Jan 7, 2025
Initiates: Buy
Price Target: $15
Current: $5.97
Upside: +151.26%
Insulet
Jan 3, 2025
Maintains: Buy
Price Target: $264 → $324
Current: $255.81
Upside: +26.66%
Dec 12, 2024
Maintains: Buy
Price Target: $100 → $110
Current: $93.53
Upside: +17.61%
Nov 18, 2024
Maintains: Buy
Price Target: $175 → $120
Current: $133.98
Upside: -10.43%
Oct 2, 2024
Initiates: Buy
Price Target: $50
Current: $1.35
Upside: +3,603.70%
Sep 6, 2024
Maintains: Hold
Price Target: $143 → $119
Current: $87.07
Upside: +36.67%
Aug 27, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $35.98
Upside: +66.76%
Aug 13, 2024
Maintains: Hold
Price Target: $83 → $80
Current: $74.88
Upside: +6.84%
Aug 8, 2024
Maintains: Buy
Price Target: $135 → $45
Current: $5.01
Upside: +798.20%
May 10, 2024
Downgrades: Hold
Price Target: $40
Current: $20.07
Upside: +99.30%
Apr 11, 2024
Maintains: Buy
Price Target: $365 → $400
Current: $369.56
Upside: +8.24%
Mar 12, 2024
Maintains: Outperform
Price Target: $50 → $60
Current: $68.18
Upside: -12.00%
Aug 4, 2023
Maintains: Outperform
Price Target: $52 → $34
Current: $19.89
Upside: +70.94%
May 11, 2023
Maintains: Outperform
Price Target: $14 → $18
Current: $7.50
Upside: +140.00%
Dec 30, 2022
Maintains: Outperform
Price Target: $6 → $25
Current: $18.13
Upside: +37.89%
Dec 13, 2022
Maintains: Outperform
Price Target: $130
Current: $109.30
Upside: +18.94%
Nov 11, 2022
Maintains: Outperform
Price Target: $7 → $5
Current: $2.19
Upside: +128.31%
May 27, 2022
Maintains: Outperform
Price Target: $125 → $117
Current: $102.96
Upside: +13.64%
Dec 7, 2021
Initiates: Outperform
Price Target: $450
Current: $2.20
Upside: +20,354.55%
Sep 3, 2020
Initiates: Outperform
Price Target: $12
Current: $14.83
Upside: -19.08%
Feb 7, 2020
Downgrades: Market Perform
Price Target: $306 → $275
Current: $203.48
Upside: +35.15%
Sep 5, 2018
Downgrades: Market Perform
Price Target: $28 → $28
Current: $10.04
Upside: +173.90%